INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

September 8, 2025

Period of Report

August 26, 2025

Accession Number

0001062993-25-015414